Bangalore Deepak, MD
Interventional Cardiology · Kansas City, MONPI 1689835084
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,468 of the $15,238 with a category attached, or 68.7%. 37 manufacturers reported payments, led by Abbott at 24.9% of the total. Reporting peaked in 2019 at $4,470 and has fallen 80.6% since, to $868 in 2025.
Across 462 payments — averaging $32.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$3K
- Boston Scientific$2K
- Edwards Lifesciences$1K
- W. L. Gore & Associates, Inc.$1K
- Amgen$423
- plus $4K from 31 others
Across 42 payments — averaging $2381.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$100K
What the payments were for
- Travel & lodging$4,73731%
- Food & beverage$10,46869%
- Education$320%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 42 | $3,800 |
| Medtronic(2 entities) | 73 | $2,972 |
| Boston Scientific | 121 | $2,220 |
| Edwards Lifesciences | 33 | $1,137 |
| W. L. Gore & Associates, Inc. | 5 | $1,046 |
| Amgen | 27 | $423 |
| Abiomed | 8 | $405 |
| Pfizer | 22 | $336 |
| Novo Nordisk | 17 | $335 |
| Shockwave Medical, Inc | 4 | $307 |
| Johnson & Johnson | 15 | $245 |
| E.r. Squibb & Sons, L.L.C. | 11 | $221 |
| Novartis | 14 | $220 |
| Angiodynamics, Inc. | 4 | $202 |
| Sanofi-aventis U.S. LLC | 10 | $161 |
| Livanova USA, Inc. | 1 | $152 |
| Boehringer Ingelheim | 8 | $139 |
| Penumbra, Inc. | 5 | $114 |
| AstraZeneca | 7 | $110 |
| Philips North America LLC | 5 | $104 |
| Cardiva Medical, Inc. | 4 | $89 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $80 |
| Irhythm Technologies, Inc. | 3 | $63 |
| Merck | 4 | $61 |
| Atricure, Inc. | 2 | $42 |
| Bayer | 2 | $34 |
| Inari Medical, Inc. | 1 | $32 |
| Lantheus Medical Imaging, Inc. | 1 | $26 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $25 |
| Teleflex LLC | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Cardinal Health 200 LLC | 1 | $14 |
| G Medical Diagnostic Services, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mitra Clip system$2,636
- CARDIOFORM Septal Occluder$989
- COREVALVE EVOLUT R$788
- Micra$201
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$199
- SAPIEN 3 Ultra RESILIA$185
- TandemLife$152
- WATCHMAN Access System$149
- GENERAL - STRUCTURAL HEART$142
- Avalus$138
- MitraClip$136
- Impella$130
- Edwards SAPIEN 3 Transcatheter Heart Valve$122
- Watchman$111
- AlphaVac$101
How this compares
$15,238 in reported general payments places this provider in the 60th percentile of 182 interventional cardiology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 118 | $145,951 |
| EliquisApixaban | 71 | $82,315 |
| XareltoRivaroxaban | 36 | $38,788 |
| Repatha SureclickEvolocumab | 26 | $29,382 |
| Repatha SyringeEvolocumab | 19 | $14,217 |
| Metoprolol Succinate | 326 | $5,097 |
| Ranolazine ErRanolazine | 24 | $3,365 |
| Atorvastatin Calcium | 357 | $2,780 |
| Prasugrel Hcl | 13 | $1,502 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 16 | $1,422 |
| Losartan Potassium | 161 | $1,210 |
| Ezetimibe | 48 | $1,193 |
| Carvedilol | 160 | $1,191 |
| ClopidogrelClopidogrel Bisulfate | 115 | $1,175 |
| Amlodipine Besylate | 214 | $1,157 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $139 | $145,951118 claims |
| PfizerEliquis | $336 | $82,31571 claims |
| Johnson & JohnsonXarelto | $245 | $38,78836 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 182 interventional cardiology providers in Missouri.
Other interventional cardiology in Kansas City
- Gerald MancusoKansas City$402K
- James GranthamKansas City$357K
- Matthew BunteKansas City$242K
- Adnan ChhatriwallaKansas City$114K
- Kenneth HuberKansas City$110K
- Chetan HudedKansas City$61K
- Adam SalisburyKansas City$52K
- Steven MarsoKansas City$42K
- Dany JacobKansas City$35K
- Muhammad Anis HaiderKansas City$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.